EMA shortages Medicine discontinued Medicine shortages
Natpar — supply shortage (medicine discontinued)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Natpar
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): parathyroid hormone
- Therapeutic area: Hypoparathyroidism
- Pharmaceutical forms affected: Powder and solvent for solution for injection
- Strengths affected: 100 micrograms/dose ;75 micrograms/dose ;50 micrograms/dose ;25 micrograms/dose
- Last updated: 09/09/2026
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗